SR59230A

CAS : 174689-39-5

Ref. 3D-ZGA68939

Informations sur le produit

• Nom: SR59230A
• Synonymes: (2S)-1-(2-Ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]2-propanol ethanedioate (1:1), (2S)-1-(2-ethylphenoxy)-3-[(1S)-1,2,3,4-tetrahydronaphthalen-1-ylamino]propan-2-ol ethanedioate (salt), 2-Propanol, 1-(2-ethylphenoxy)-3-[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]-, [S-(R*,R*)]-, ethanedioate (1:1) (salt), 2-Propanol, 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]-, (2S)-, ethanedioate (1:1), 2-Propanol, 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]-, (2S)-, ethanedioate (1:1) (salt), 3-(2-Ethylphenoxy)-1-[[(1S)-1,2,3,4-tetrahydronaphth-1-yl]amino]-(2S)-2-propanol oxalate salt, SR59230AHCl, Sr 59230A, Sr 59230A Hydrochloride

Description

SR59230A is a monoclonal antibody that has been shown to inhibit the activity of the protein uncoupling protein 2 (UCP2). This leads to an increase in cellular energy expenditure, thereby lowering blood pressure and improving metabolic disorders. SR59230A also has anti-inflammatory effects, which may be due to its inhibition of pro-inflammatory cytokines, such as TNF-α and IL-1β. SR59230A has been shown to reduce the levels of camp, a chemical that regulates metabolism, in mice with type 1 diabetes. SR59230A is being investigated for use in treating cardiac disease and other symptoms related to cardiovascular disease.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 415.5 g/mol
• Formule: C₂₃H₂₉NO₆
• Degré de pureté: Min. 95%